Adverse drug events associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of autoimmune diseases: A systematic review and meta-analysis of randomized…

Overview of attention for article published in Clinical Rheumatology, September 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 57 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 9,597 followers.

RT @PVpapers: #AdverseDrugEvents associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of auto…

03 Oct 2018

Reply Repost Favourite

#AdverseDrugEvents associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials https://t.co/ByD5Bs6rnl

03 Oct 2018

Reply Repost Favourite

RT @montaneva: Adverse drug events associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of au…

23 Sep 2018

Reply Repost Favourite

Adverse drug events associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials. https://t.co/Utf2u96uXM #PubMed

23 Sep 2018

Reply Repost Favourite